Arginine hydrochloride

DRUG8 trials

Sponsors

UCSF Benioff Children's Hospital Oakland, Dauntless Pharmaceuticals, The First Affiliated Hospital of Zhengzhou University, Zujiang YU, Emory University

Conditions

Anemia, Sickle CellCOVID-19CancerDiabetes (DM)Diabetic KetoacidosisHCCHealthy Volunteer StudyHyperglycaemia (Diabetic)

Phase 1

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

CompletedNCT03031535

Dauntless PharmaceuticalsHealthy Volunteer Study

Start: 2017-01-31End: 2017-03-31Updated: 2017-05-12

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

RecruitingNCT07167693

David K CarrollDiabetes (DM), Diabetic Ketoacidosis, Hyperglycaemia (Diabetic) +1

Start: 2025-12-19End: 2027-12-31Target: 60Updated: 2026-02-12

Phase 2

Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

CompletedNCT00029731

UCSF Benioff Children's Hospital OaklandAnemia, Sickle Cell, Pneumonia

Start: 2001-08-31End: 2005-07-31Target: 30Updated: 2015-03-25

Arginine Replacement Therapy in COVID-19

RecruitingNCT05855330

Emory UniversityCOVID-19

Start: 2024-01-08End: 2027-06-30Target: 21Updated: 2025-04-03

Phase 3

Treatment of Intermediate-stage Hepatocellular Carcinoma

The First Affiliated Hospital of Zhengzhou UniversityHCC

Start: 2017-07-18End: 2021-07-31Target: 300Updated: 2017-09-15

Treatment of Advanced Hepatocellular Carcinoma

The First Affiliated Hospital of Zhengzhou UniversityHCC

Start: 2017-07-18End: 2021-07-31Target: 300Updated: 2017-09-12

Prevention of Cancer Development and Progression

Zujiang YUCancer

Start: 2019-05-10End: 2025-05-10Target: 300Updated: 2019-05-07

Novel Treatment of Advanced Hepatocellular Carcinoma

The First Affiliated Hospital of Zhengzhou UniversityHCC

Start: 2019-04-10End: 2023-04-10Target: 300Updated: 2019-05-15